Related Experiment Video
Updated: Jul 14, 2026

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells
Published on: August 12, 2015
Bcl-2 gene silencing in pediatric epithelial liver tumors
Steven W Warmann1, Heike Frank, Heike Heitmann
1Department of Pediatric Surgery, University Children's Hospital Tübingen, Tübingen, Germany. steven.warmann@med.uni-tuebingen.de
Background:
Proteins of the Bcl-2 family prevent cells of various tumor types from undergoing apoptosis and thus contribute to their chemotherapy resistance. The phenotype of multidrug resistance is a major factor for poor treatment results of advanced epithelial liver tumors in children. The role of Bcl-2 proteins in these tumors is yet unclear. The purpose of this study was to analyze the influence of Bcl-2 on the chemotherapy resistance of hepatoblastoma (HB) and pediatric hepatocellular carcinoma (HCC).
Materials And Methods:
Bcl-2 expression was analyzed in the HB cell lines HUH6 and HepT1 as well as in the HCC cell line HepG2 before and after treatment with cisplatin, doxorubicin, taxol, and etoposid. Silencing of the Bcl-2 gene was performed via RNA interference using specific siRNA. Treatment efficiencies of cytotoxic agents were assessed against original and Bcl-2 siRNA transfected tumor cells.
Results:
The mixed HB cell line HUH6 showed a relevant amount of Bcl-2 expression, which increased after chemotherapy. In these cells Bcl-2 appeared within the nuclei and the cytosol. Treatment with all cytotoxic agents was significantly improved through Bcl-2 siRNA (P < 0.001-0.0054) in this cell line. There was no effect of Bcl-2 siRNA in HepT1 and HepG2 cells.
Conclusions:
Bcl-2 seems to play a role in antiapoptotic mechanisms of some HB subtypes. Thus, this gene might serve as target for a gene-directed adjuvant therapy. Further studies seem necessary to clear the susceptibility of pediatric epithelial liver tumors toward the described approach.
Insights
Bcl-2 gene silencing improved chemotherapy effectiveness in some pediatric liver cancer cells, suggesting it could be a target for new treatments. Further research is needed for other tumor types.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Bcl-2 family proteins inhibit apoptosis, contributing to multidrug resistance in various cancers.
- Multidrug resistance significantly impacts treatment outcomes for pediatric epithelial liver tumors.
- The specific role of Bcl-2 in hepatoblastoma (HB) and hepatocellular carcinoma (HCC) remains largely uncharacterized.
Purpose of the Study:
- To investigate the influence of Bcl-2 on chemotherapy resistance in pediatric liver tumors, specifically HB and HCC.
- To determine if targeting Bcl-2 can overcome chemotherapy resistance in these pediatric liver cancers.
Main Methods:
- Analyzed Bcl-2 expression in HB (HUH6, HepT1) and HCC (HepG2) cell lines before and after chemotherapy.
- Utilized RNA interference (siRNA) to silence the Bcl-2 gene in tumor cells.
- Assessed the efficacy of cytotoxic agents (cisplatin, doxorubicin, taxol, etoposide) on both original and Bcl-2-silenced cells.
Main Results:
- HUH6 cells, a mixed HB line, exhibited increased Bcl-2 expression post-chemotherapy, localized in nuclei and cytosol.
- Bcl-2 siRNA significantly enhanced the effectiveness of all tested cytotoxic agents in HUH6 cells (P < 0.001–0.0054).
- Bcl-2 siRNA demonstrated no significant effect on chemotherapy resistance in HepT1 (HB) and HepG2 (HCC) cell lines.
Conclusions:
- Bcl-2 appears to mediate antiapoptotic functions in specific subtypes of hepatoblastoma.
- The Bcl-2 gene represents a potential target for gene-directed adjuvant therapy in certain pediatric liver cancers.
- Additional research is required to fully elucidate the susceptibility of pediatric epithelial liver tumors to Bcl-2 targeting strategies.
Related Concept Videos
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Abnormal Proliferation
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
